Furthermore, high HDGF expression correlates with poor prognosis in patients with hepatocellular carcinoma, pancreatic cancer, cholangiocarcinoma, gallbladder adenocarcinoma, and esophageal cancer (10). This evidence concerns the gene HDGF and hepatocellular carcinoma.